Login / Signup

Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.

Rasmus Juul KildemoesChristian HollensenBeverly M K BillerGudmundur JohannssonYutaka TakahashiMichael Højby Rasmussen
Published in: European journal of endocrinology (2022)
This study extends the knowledge of the somapacitan dose-IGF-I response and provides information on clinical dosing of once-weekly somapacitan in patients with AGHD.
Keyphrases
  • growth hormone
  • healthcare
  • binding protein
  • pi k akt
  • health information
  • replacement therapy
  • smoking cessation